A New Thiopurine S-Methyltransferase Haplotype Associated With Intolerance to Azathioprine

被引:15
作者
Colleoni, Lara [1 ]
Kapetis, Dimos [1 ]
Maggi, Lorenzo [1 ]
Camera, Giorgia [1 ]
Canioni, Eleonora [1 ]
Cavalcante, Paola [1 ]
de Rosbo, Nicole Kerlero [1 ]
Baggi, Fulvio [1 ]
Antozzi, Carlo [1 ]
Confalonieri, Paolo [1 ]
Mantegazza, Renato [1 ]
Bernasconi, Pia [1 ]
机构
[1] Fdn IRCCS Neurol Inst Carlo Besta, Milan, Italy
关键词
thiopurine S-S; azathioprine; single nucleotide polymorphism; haplotype; myasthenia gravis; INFLAMMATORY-BOWEL-DISEASE; MYASTHENIA-GRAVIS; ALLELIC VARIANTS; PHARMACOGENETICS; GENE; 6-MERCAPTOPURINE; POLYMORPHISMS; MECHANISM; DRUGS;
D O I
10.1177/0091270011435989
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The authors have analyzed single nucleotide polymorphisms in the thiopurine S-methyltransferase (TPMT) gene in the context of efficacy and toxicity of azathioprine (AZA) to determine possible genotype-phenotype correlations between TPMT allelic variants and response to AZA treatment in 76 Italian patients with myasthenia gravis. They confirm known intronic and exonic TPMT polymorphisms that do not correlate with AZA responses and demonstrate a novel intronic polymorphism in a patient intolerant to AZA. Most importantly, they show that of the 22 AZA-intolerant patients, all 5 who carried mutations of the intolerance-linked haplotype TPMT*3A also carried the intronic T140+114A (rs3931660), all 3 mutations being part of a new haplotype designated TMPT*3E. TPMT*3E was not observed in unresponsive or responsive patients. The association of TPMT*3E with AZA intolerance and its frequency must be ascertained in larger, ethnically different cohorts. Nevertheless, in view of the highly significant association (Psim = 0.0026) between TPMT*3E and AZA intolerance in the study, this new haplotype should be taken into consideration in pharmacogenetic profiling for AZA.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 40 条
[1]   Thiopurine methyltransferase alleles in British and Ghanaian populations [J].
Ameyaw, MM ;
Collie-Duguid, ESR ;
Powrie, RH ;
Ofori-Adjei, D ;
McLeod, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :367-370
[2]   Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease [J].
Ansari, A. ;
Arenas, M. ;
Greenfield, S. M. ;
Morris, D. ;
Lindsay, J. ;
Gilshenan, K. ;
Smith, M. ;
Lewis, C. ;
Marinaki, A. ;
Duley, J. ;
Sanderson, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (08) :973-983
[3]   Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene [J].
Appell, Malin Lindqvist ;
Wennerstrand, Patricia ;
Peterson, Curt ;
Hertervig, Erik ;
Martensson, Lars-Goran .
PHARMACOGENETICS AND GENOMICS, 2010, 20 (11) :700-707
[4]   The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease [J].
Ban, Hiromistu ;
Andoh, Akira ;
Imaeda, Hirotsugu ;
Kobori, Ayako ;
Bamba, Shigeki ;
Tsujikawa, Tomoyuki ;
Sasaki, Masaya ;
Saito, Yasuharu ;
Fujiyama, Yoshihide .
JOURNAL OF GASTROENTEROLOGY, 2010, 45 (10) :1014-1021
[5]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[6]  
Cara CJ, 2004, MED SCI MONITOR, V10, pRA247
[7]   THERAPEUTIC TRIAL OF IMURAN (AZATHIOPRINE) IN MULTIPLE SCLEROSIS [J].
CENDROWSKI, WS .
ACTA NEUROLOGICA SCANDINAVICA, 1971, 47 (02) :254-+
[8]  
Cheon JH, 2009, HEPATO-GASTROENTEROL, V56, P421
[9]   The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs [J].
Coulthard, SA ;
Hogarth, LA ;
Little, M ;
Matheson, EC ;
Redfern, CPF ;
Minto, L ;
Hall, AG .
MOLECULAR PHARMACOLOGY, 2002, 62 (01) :102-109
[10]  
de Boer NKH, 2005, NETH J MED, V63, P444